Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19814065 | 0.85 | KIF11 (0.61) | KIF11 | |
| SCHEMBL1526445 | 0.79 | KIF11 (0.57) | KIF11 | |
| SCHEMBL1648406 | 0.78 | KIF11 (0.50) | KIF11 | |
| SCHEMBL28658067 | 0.75 | KIF11 (0.54) | KIF11DNMT1 | |
| SCHEMBL34230 | 0.74 | KIF11 (0.50) | KIF11 | |
| SCHEMBL20545942 | 0.74 | PAM (0.46) | KIF11DNMT1 | |
| Acetic Acid SCHEMBL329771 | 0.74 | KIF11 (0.48) | KIF11DNMT1 | |
| SCHEMBL18176011 | 0.71 | KIF11 (0.52) | KIF11 | |
| SCHEMBL19119641 | 0.71 | KIF11 (0.44) | KIF11 | |
| SCHEMBL974721 | 0.71 | KIF11 (0.63) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4561634-A1 | AURISTATIN DERIVATIVES AND CONJUGATES THEREOF | MediBoston Limited (HK) | 2025-06-04 | — | — | EP | disclosed |
| CN-119894535-A | Oritastatin derivatives and conjugates thereof | 祐方有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20240108744-A1 | AURISTATIN DERIVATIVES AND CONJUGATES THEREOF | FORTVITA BIOLOGICS LIMITED (CN) | 2024-04-04 | — | — | US | disclosed |
| WO-2024023735-A1 | AURISTATIN DERIVATIVES AND CONJUGATES THEREOF | MEDIBOSTON LIMITED (CN) | 2024-02-01 | — | — | WO | disclosed |
| CN-104324394-A | Molecular probe developer, as well as preparation method and application thereof | CHENGDU YAOHANG TECHNOLOGY CO LTD | 2015-02-04 | — | — | CN | disclosed |
| US-8747810-B2 | Compositions and methods for imaging tissues, organs and tumors | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-06-10 | — | — | US | disclosed |
| US-8747810-B2 | Compositions and methods for imaging tissues, organs and tumors | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-06-10 | — | — | US | disclosed |
| US-20120269724-A1 | COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-10-25 | — | — | US | disclosed |
| US-20120269724-A1 | COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-10-25 | — | — | US | disclosed |
| US-8198218-B2 | Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2012-06-12 | — | — | US | disclosed |
| EP-2440584-A1 | COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS | President and Fellows of Harvard College (US) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010144891-A1 | COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-12-16 | — | — | WO | disclosed |
| WO-2010144891-A1 | COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-12-16 | — | — | WO | disclosed |
| US-20100022499-A1 | HETEROCYCLIC COMPOUNDS, COMBINATORIAL LIBRARIES THEREOF AND METHODS OF SELECTING DRUG LEADS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM | 2010-01-28 | — | — | US | disclosed |
| US-20090118140-A1 | METHOD AND SYSTEM FOR ASSEMBLY OF MACROMOLECULES AND NANOSTRUCTURES | XF TECHNOLOGIES INC. | 2009-05-07 | — | — | US | disclosed |
| WO-2008112980-A2 | METHOD AND SYSTEM FOR ASSEMBLY OF MACROMOLECULES AND NANOSTRUCTURES | INCITOR, LLC (US) | 2008-09-18 | — | — | WO | disclosed |
| US-20030207400-A1 | Vectors for dna delivery | BIANCHI ELISABETTA (IT) | 2003-11-06 | — | — | US | disclosed |
| EP-0618221-A2 | Heterocyclic inhibitors of farnesyl protein transferase | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120269724-A1 | COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS | SSTR3, TACR1, SSTR5 | KIF11 4726/4885DNMT1 3680/4885 |
| US-20240108744-A1 | AURISTATIN DERIVATIVES AND CONJUGATES THEREOF | AURKA, AURKC, AURKB | KIF11 227/4885DNMT1 1067/4885 |
| US-20100022499-A1 | HETEROCYCLIC COMPOUNDS, COMBINATORIAL LIBRARIES THEREOF AND METHODS OF SELECTING DRUG LEADS | AADAC, ABCG2, RICTOR | KIF11 3214/4885DNMT1 4449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.